2016
DOI: 10.5694/mja16.00368
|View full text |Cite
|
Sign up to set email alerts
|

National Heart Foundation of Australia and Cardiac Society of Australia and New Zealand: Australian clinical guidelines for the management of acute coronary syndromes 2016

Abstract: This guideline provides advice on the standardised assessment and management of patients with suspected ACS, including the implementation of clinical assessment pathways and subsequent functional and anatomical testing. It provides guidance on the: diagnosis and risk stratification of ACS; provision of acute reperfusion therapy and immediate post-fibrinolysis care for patients with ST segment elevation myocardial infarction; risk stratification informing the use of routine versus selective invasive management … Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1

Citation Types

3
134
1
1

Year Published

2017
2017
2022
2022

Publication Types

Select...
10

Relationship

2
8

Authors

Journals

citations
Cited by 152 publications
(139 citation statements)
references
References 47 publications
3
134
1
1
Order By: Relevance
“…6,7 On the basis of this trial, ticagrelor is now recommended as first-line therapy for patients with ACS in international guidelines. [8][9][10] Although ticagrelor represents advancement in antiplatelet therapy, several adverse effects have been reported. 11,12 In the PLATO trial, treatment with ticagrelor resulted in a small but significant increase in noncoronary artery bypass grafting (CABG)-related major bleeding when compared to clopidogrel.…”
Section: Introductionmentioning
confidence: 99%
“…6,7 On the basis of this trial, ticagrelor is now recommended as first-line therapy for patients with ACS in international guidelines. [8][9][10] Although ticagrelor represents advancement in antiplatelet therapy, several adverse effects have been reported. 11,12 In the PLATO trial, treatment with ticagrelor resulted in a small but significant increase in noncoronary artery bypass grafting (CABG)-related major bleeding when compared to clopidogrel.…”
Section: Introductionmentioning
confidence: 99%
“…Statins are a widely used class of drugs that has an established benefit in patients with ischaemic heart disease (IHD) at the highest tolerated doses [1–3]. Statin associated rhabdomyolysis (SAR), although rare, is a well-recognized life threatening adverse effect [4].…”
Section: Introductionmentioning
confidence: 99%
“…Within improved protocols for chest pain assessment and diagnosis, early coronary angiography for high-risk chest pain is increasingly emphasised [97]. Rates of emergent coronary angiography in reported cases of P-SCAD have significantly increased across the documented time periods.…”
Section: Management and Outcomesmentioning
confidence: 99%